Since the launch of its Flowflex Plus COVID-19 and Flu A/B Home Test, ACON Laboratories, Inc. has continued testing for product stability to extend the shelf-life. These results have been shared with the FDA. We are pleased to announce that the request to extend the...
NACDS NACDS Annual Meeting April 26-29, 2025 The Breakers Palm Beach, Florida ECRM Private Label Health & Beauty Care Session April 7-9, 2025 Hyatt Regency Chicago O’Hare Rosemont, Illinois ECRM Diabetes, Diagnostics & Clinical Session May 5-8, 2025 Hyatt...
SAN DIEGO, CA., July 29, 2024 – ACON Laboratories, Inc., a leading global medical device manufacturer for 25 years, announced today that its Flowflex® Plus COVID-19 and Flu A/B Home Test has been authorized for emergency use by the U.S. Food and Drug Administration....
ECRM Diabetes, Diagnostics& Clinical Session May 8-11, 2024 Westin Kansas City at Crown Center Kansas City, Missouri ADLM (formerly AACC) Association for Diagnostics & Laboratory Medicine July 28-August 1, 2024 McCormick Place Convention Center Chicago,...
ACON Laboratories, Inc. has been continuously monitoring the emergence of SARS-CoV-2 variants. According to the Centers for Disease Control and Prevention (CDC) COVID Data Tracker, the Omicron variant remains the dominant variant circulating in the United States....
